慢加急性肝衰竭前期患者血清M30和M65水平预测预后价值探讨

被引:6
作者
黄小平 [1 ]
吴云辉 [2 ]
王艳 [1 ]
甘建和 [1 ]
机构
[1] 苏州大学附属第一医院感染病科
[2] 浙江省嘉兴县人民医院感染病科
关键词
慢加急性肝衰竭; 慢加急性肝衰竭前期; 早期诊断; M30抗原; M65抗原;
D O I
暂无
中图分类号
R575.3 [肝功能衰竭];
学科分类号
100201 [内科学];
摘要
目的探讨慢加急性肝衰竭前期(pre-ACLF)患者血清M30和M65水平在早期诊断慢加急性肝衰竭(ACLF)患者的价值。方法采用ELISA法检测35例pre-ACLF患者(痊愈20例、进展15例)、40例HBV相关ACLF患者(生存20例,死亡20例)、20例慢性乙型肝炎患者(CHB)和20例健康对照者血清M30和M65水平,分析其对pre-ACLF及ACLF患者临床转归的预测价值。结果 ACLF组和pre-ACLF组血清M30和M65水平均显著高于健康对照组或CHB患者,ACLF组显著高于pre-ACLF组(P<0.05);pre-ACLF进展组血清M30和M65[分别为(493.80±143.85)U/L和(712.47±305.67)U/L],与痊愈组[分别为(351.40±127.78)U/L和(448.15±165.14)U/L]比,差异具有统计学意义(P<0.05);pre-ACLF进展组与ACLF患者比,血清M30和M65水平[分别为(503.29±184.43)U/L和(746.99±275.19)U/L],均无显著性差异(P>0.05);以血清M30和M65水平鉴别诊断Pre-ACLF临床转归的ROC曲线下面积(AUC)分别为0.877和0.867;当M30≥453.70 U/L时,其预测预后的灵敏度和特异度分别为0.867和0.850;当M65≥626.71 U/L时,其早期预测ACLF的灵敏度和特异度分别为0.800和0.850。死亡的ACLF患者血清M30和M65水平虽高于ACLF好转组,但差异无统计学意义。结论 M30和M65是反应肝衰竭及肝衰竭前期患者肝细胞坏死或凋亡较敏感的指标,可用于早期诊断ACLF。
引用
收藏
页码:301 / 304
页数:4
相关论文
共 12 条
[1]
Mechanismof cell death in acute-on-chronic liver failure: a clinico-pathologic-biomarker study [J].
Adebayo, Danielle ;
Morabito, Vincenzo ;
Andreola, Fausto ;
Pieri, Giulia ;
Tu-Vin Luong ;
Dhillon, Amar ;
Mookerjee, Rajeshwar ;
Jalan, Rajiv .
LIVER INTERNATIONAL, 2015, 35 (12) :2564-2574
[2]
Soluble intracellular adhesion molecule, M30 and M65 as serum markers of disease activity and prognosis in cholestatic liver diseases [J].
Denk, Gerald ;
Omary, Ahmed-Jawid ;
Reiter, Florian Paul ;
Hohenester, Simon ;
Wimmer, Ralf ;
Holdenrieder, Stefan ;
Rust, Christian .
HEPATOLOGY RESEARCH, 2014, 44 (13) :1286-1298
[3]
Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases [J].
Duan, Bin-Wei ;
Lu, Shi-Chun ;
Wang, Meng-Long ;
Liu, Jin-Ning ;
Chi, Ping ;
Lai, Wei ;
Wu, Ju-Shan ;
Guo, Qing-Liang ;
Lin, Dong-Dong ;
Liu, Yuan ;
Zeng, Dao-Bing ;
Li, Chuan-Yun ;
Meng, Qing-Hua ;
Ding, Hui-Guo ;
Chen, Xin-Yue ;
Liao, Hui-Yu ;
Ma, Lie-Qing ;
Chen, Yu ;
Zhang, Jing ;
Xiang, Hai-Ping ;
Duan, Zhong-Ping ;
Li, Ning .
JOURNAL OF SURGICAL RESEARCH, 2013, 183 (02) :936-943
[4]
Development of an Accurate Index for Predicting Outcomes of Patients With Acute Liver Failure [J].
Rutherford, Anna ;
King, Lindsay Y. ;
Hynan, Linda S. ;
Vedvyas, Chetan ;
Lin, Wenyu ;
Lee, William M. ;
Chung, Raymond T. .
GASTROENTEROLOGY, 2012, 143 (05) :1237-1243
[5]
Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure.[J].Hitendra Garg;Ashish Kumar;Vishal Garg;Praveen Sharma;Barjesh Chander Sharma;Shiv Kumar Sarin.Digestive and Liver Disease.2011, 2
[6]
Apoptosis versus necrosis rate as a predictor in acute liver failure following acetaminophen intoxication compared with acute‐on‐chronic liver failure.[J].Lars P.Bechmann;GuidoMarquitan;ChristophJochum;FuatSaner;GuidoGerken;AliCanbay.Liver International.2007, 5
[7]
Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B [J].
Tsubota, A ;
Arase, Y ;
Suzuki, Y ;
Suzuki, F ;
Sezaki, H ;
Hosaka, T ;
Akuta, N ;
Someya, T ;
Kobayashi, M ;
Saitoh, S ;
Ikeda, K ;
Kumada, H .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (03) :426-432
[8]
Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis [J].
Leers, MPG ;
Kölgen, W ;
Björklund, V ;
Bergman, T ;
Tribbick, G ;
Persson, B ;
Björklund, P ;
Ramaekers, FCS ;
Björklund, B ;
Nap, M ;
Jörnvall, H ;
Schutte, B .
JOURNAL OF PATHOLOGY, 1999, 187 (05) :567-572
[9]
HBV相关慢加急性肝衰竭前期概念及诊疗新进展 [J].
李晨 ;
游绍莉 ;
辛绍杰 .
实用肝脏病杂志, 2015, 18 (01) :105-108
[10]
Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure [J].
Zheng, Su-Jun ;
Liu, Shuang ;
Liu, Mei ;
McCrae, Malcolm A. ;
Li, Jun-Feng ;
Han, Yuan-Ping ;
Xu, Chun-Hui ;
Ren, Feng ;
Chen, Yu ;
Duan, Zhong-Ping .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (09) :2403-2411